DropsDrops
Schedule H (Prescription Required)Antibacterial Eye & Ear DropsCode: 1432

Tobramycin Eye Drops 0.3%w/v

Generic Formulation:Tobramycin Eye Drops 0.3%w/v
Pack Size:5 ml Vial
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹25
Brand Estimate*
₹111.21
Estimated Savings:₹86.21 (78% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Tobramycin (0.3% w/v eye drops) is a water-soluble aminoglycoside bactericidal antibiotic. It binds to the 30S ribosomal subunit, disrupting protein synthesis. Exhibits potent bactericidal activity against Pseudomonas aeruginosa, Proteus, and staphylococci. Indicated for external bacterial infections of the eye and surrounding adnexa (blepharitis, conjunctivitis, keratitis).

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1432.Report inaccuracy

Usage Guidelines

Instill one to two drops into the affected eye(s) every 4 hours for mild-to-moderate infections, or every 1 to 2 hours for severe corneal infections until improvement.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Transient eye burning, stinging, conjunctival erythema, eyelid itching/swelling. Rare/Severe: Corneal toxicity (punctate epithelial keratopathy) and hypersensitivity.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Cross-sensitivity with other aminoglycosides may occur. Do not wear contact lenses during treatment. Discontinue if localized sensitization occurs.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or ophthalmic treatment recommendations. Always consult a registered ophthalmologist or ENT specialist before initiating, changing, or instilling any ophthalmic or otic medication.